Ritonavir

• A Phase 2/3 Safety, Pharmacokinetics, and Efficacy Study ofNirmatrelvir/Ritonavir in Pediatric, Nonhospitalized Symptomatic Participants Wit… Recruiting
  2023-509773-23-00 Phase II/III 2 countries Pfizer Inc.
• Interventional, multicenter, open-label, randomized, non-comparative trial evaluating the safety, in terms of HBV virological control, of 2 … Recruiting
  2023-508634-34-00 Phase II 1 country Inserm
• Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1 ( ISLEND-… Ended
  2024-514047-28-00 Phase III 4 countries Gilead Sciences Inc.
• Antiviral treatment for long covid. Ended
  2023-510337-29-00 Phase III 1 country Helse Bergen HF
• A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who are Healthy Volunteers Co-administered the Medicine Ro… Ended
  2023-503570-20-00 Phase I (Other) 1 country Pfizer Inc.
• Study on Pharmacokinetics of newly developed ANtiretroviral agents in HIV-infected pregNAnt women (PANNA) Ended
  2024-515487-31-00 Phase IV 5 countries Stichting Radboud universitair medisch centrum

Showing 1–6 of 6 trials